Clinical Trial Update: Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating immunotherapy or targeted therapy with or without stereotactic radiosurgery for brain metastases from melanoma or non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Non-Small Cell Lung Cancer, Melanoma | Phase 3 | Status: RECRUITING